Dudediligence.

Tempest Therapeutics, Inc

TPSTNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$10.6MSep ’24−$13.8MDec ’24−$10.9MMar ’25−$7.9MJun ’25−$3.5MSep ’25−$4.0MDec ’25−$27.7MMar ’26−$5.2MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating income−$27.0M−$34.6M−$29.2M−$42.0M−$26.6M
Net income−$28.3M−$35.7M−$29.5M−$41.8M−$26.3M
Operating cash flow−$26.0M−$31.1M−$27.4M−$33.0M−$26.8M
Free cash flow−$26.1M−$31.6M−$27.5M−$33.5M−$26.8M
Cash$51.8M$31.2M$39.2M$30.3M$7.7M
Debt$15.1M$10.4M$10.5M$6.4M$0.00
Shares outstanding6.9M10.5M22.0M3.4M4.9M